Response rates and early deaths for patients who received ven/aza or IC
| Variable . | Ven/aza . | IC . | P (ven/aza vs IC) . |
|---|---|---|---|
| Response | |||
| CR | 89 (62.2) | 96 (64.4) | |
| CRi | 13 (9.1) | 4 (2.7) | |
| MLFS | 8 (5.6) | 5 (3.4) | |
| Overall response (CR + CRi + MLFS) | 110/143 (76.9) | 105/149 (70.5) | .2109 |
| Death | |||
| Within 30 d of treatment | 7 (4.9) | 8 (5.4) | .8545 |
| Variable . | Ven/aza . | IC . | P (ven/aza vs IC) . |
|---|---|---|---|
| Response | |||
| CR | 89 (62.2) | 96 (64.4) | |
| CRi | 13 (9.1) | 4 (2.7) | |
| MLFS | 8 (5.6) | 5 (3.4) | |
| Overall response (CR + CRi + MLFS) | 110/143 (76.9) | 105/149 (70.5) | .2109 |
| Death | |||
| Within 30 d of treatment | 7 (4.9) | 8 (5.4) | .8545 |
Data are presented as n (%) or n/N (%).
CR, complete remission; CRi, complete remission with incomplete recovery of peripheral blood counts; MLFS, morphological leukemia-free state.